Evidence map›Paper›PMID 39919189›Full record

ArticleScience advances2025

A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform.

Yingying Jiang, Mrinmoy Sanyal, Noor A Hussein, Ani Baghdasaryan, Mengzhen Zhang, Feifei Wang, Fuqiang Ren, Jiachen Li, Guanzhou Zhu, Yifan Meng and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yingying JiangDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0009-0000-5285-2211
Mrinmoy SanyalSarafan ChEM-H, Stanford University, Stanford, CA, USA.ORCID 0000-0002-1365-4279
Noor A HusseinDepartment of Pediatrics, Stanford University, Stanford, CA, USA.
Ani BaghdasaryanDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0003-1324-5683
Mengzhen ZhangDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.
Feifei WangDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0001-7687-3412
Fuqiang RenDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.
Jiachen LiDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0001-8311-4043
Guanzhou ZhuDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0001-8829-4776
Yifan MengDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0001-6897-3595
Julia Zofia AdamskaInstitute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0001-8657-4141
Elizabeth MellinsDepartment of Pediatrics, Stanford University, Stanford, CA, USA.ORCID 0000-0003-2577-139X
Hongjie DaiDepartment of Chemistry and Bio-X, Stanford University, Stanford, CA, USA.ORCID 0000-0002-8541-5752

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Human Infrared Vision at Molecular and Cellular ScaleDP1NS105737 · NINDS · STANFORD UNIVERSITY · PI DAI, HONGJIE · 2017 to 2022
$5.5M
NIAID NIH HHS T32 AI007290NINDS NIH HHS DP1 NS105737
6 · The paper itself

Abstract

The COVID-19 pandemic caused a global health crisis that resulted in millions of deaths. Effective vaccines have played central roles in curtailing the pandemic. Here, we developed a down-converting near-infrared IIb (NIR-IIb; 1500 to 1700 nanometers) luminescent, pure NaErF

Indexed as

COVID-19COVID-19 VaccinesNanoparticlesSARS-CoV-2AnimalsAntibodies, NeutralizingAntibodies, ViralFemaleHumansInfrared RaysLymph NodesMiceSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID39919189
PMCPMC11804919

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.